Category
Chair, Speaker
IATDMCT
International Association of Therapeutic Drug Monitoring
and Clinical Toxicology
It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the Congress was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated, as well as the Helsinki Declaration 1975 as revised in 1996. The protocol of the study must be approved by the Institutional Review Board (IRB) or the equivalent (e.g., Research Ethics Board) where the study is conducted. Authors should mask patients’ eyes and remove patients’ names from figures unless they obtain written consent from the patients.